Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings | Journal of Pharmacology and Experimental Therapeutics
Untitled Document
Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy | British Journal of Cancer
Synthesis of Potential Anti-inflammatory Compounds, Selective Inhibitors of Cyclooxygenase-2 (COX-2)
Discovery and development of cyclooxygenase 2 inhibitors - Wikipedia
Celecoxib and Bcl-2: emerging possibilities for anticancer drug design | Future Medicinal Chemistry
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesiss⃞ - Journal of Lipid Research
Cardiovascular effects and safety of (non-aspirin) NSAIDs | Nature Reviews Cardiology